共 50 条
- [22] Effect of Elagolix Exposure on Clinical Efficacy End Points in Phase III Trials in Women With Endometriosis-Associated Pain: An Application of Markov Model CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2020, 9 (08): : 466 - 475
- [26] Impact of Elagolix on Workplace and Household Productivity Among Women with Moderate to Severe Pain Associated with Endometriosis: A Pooled Analysis of Two Phase III Trials The Patient - Patient-Centered Outcomes Research, 2019, 12 : 651 - 660
- [27] Impact of Elagolix on Workplace and Household Productivity Among Women with Moderate to Severe Pain Associated with Endometriosis: A Pooled Analysis of Two Phase III Trials PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2019, 12 (06): : 651 - 660
- [30] Long-Term Safety of Elagolix With Add-Back in Women With Endometriosis-Associated Pain: 36-Month Results OBSTETRICS AND GYNECOLOGY, 2023, 141 : 13S - 13S